TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
FDMT

4D Molecular Therapeutics Inc

Healthcare · Biotechnology · —

15.20$ +3.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement FDMT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
+144.0% -50.6% +94.8% +32.5% -82.7% +562.3% -99.8% +230,194.6%
+35.3% +110.9% +37.0% -94.3% +28.5% +2,402.5% +45.5% -94.6%
-82.7% -2,540.8%
+35.3% +138.8% +20.9% +15.7% +30.8% +21.0% +45.5% +38.5%
+76.8% +125.3% +24.1% +62.5% +17.5% +10.9% +27.6% +5.3%
+43.8% -22.4% -9.4% +418.5% +26.6% -67.8% +27.6% +409.1%
+1,897.4% +111.4%
+328.4% -104.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?